{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:02:52Z","timestamp":1779163372828,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jjcc.2025.06.001","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:20:29Z","timestamp":1749583229000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["RNF213 and cardiovascular disease: A review of histopathological, genetic perspectives, and potential molecular mechanisms"],"prefix":"10.1016","volume":"87","author":[{"given":"Toshinaru","family":"Kawakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Isagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kuchimaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2025.06.001_bb0005","article-title":"Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development","volume":"6","author":"Liu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first moyamoya disease gene","volume":"56","author":"Kamada","year":"2011","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0015","first-page":"86","article-title":"Adult moyamoya disease and moyamoya syndrome: what is new?","volume":"14","author":"Uchiyama","year":"2024","journal-title":"Cerebrovasc Dis Extra"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102281","article-title":"Insights into the regulatory role of epigenetics in moyamoya disease: current advances and future prospectives","volume":"35","author":"Xu","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/jb\/mvae020","article-title":"Molecular structure and function of mysterin\/RNF213","volume":"175","author":"Morito","year":"2024","journal-title":"J Biochem"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.wneu.2017.01.012","article-title":"Moyamoya and inflammation","volume":"100","author":"Mejia-Munne","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0035","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s12975-019-00743-6","article-title":"Moyamoya disease and spectrums of RNF213 vasculopathy","volume":"11","author":"Bang","year":"2020","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0040","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56185","article-title":"Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism","volume":"9","author":"Ahel","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0045","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1083\/jcb.201712120","article-title":"The AAA+ ATPase\/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets","volume":"218","author":"Sugihara","year":"2019","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2022.04.007","article-title":"Suppression of RNF213, a susceptibility gene for moyamoya disease, inhibits endoplasmic reticulum stress through SEL1L upregulation","volume":"609","author":"Ahmed","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0055","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","article-title":"Moyamoya disease emerging as an immune-related angiopathy","volume":"28","author":"Asselman","year":"2022","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145340","article-title":"New insights into TNF\u03b1\/PTP1B and PPAR\u03b3 pathway through RNF213- a link between inflammation, obesity, insulin resistance, and Moyamoya disease","volume":"771","author":"Sarkar","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175649","article-title":"Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease","volume":"12","author":"Morimoto","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.23838\/pfm.2022.00009","article-title":"Systemic vasculopathy associated with an RNF213 p.Arg4810Lys variant in moyamoya disease: a review","volume":"6","author":"Kim","year":"2022","journal-title":"Precis Future Med"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1272\/jnms.JNMS.2024_91-215","article-title":"RNF213-related vasculopathy: various systemic vascular diseases involving RNF213 gene mutations: review","volume":"91","author":"Murai","year":"2024","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0080","first-page":"555","article-title":"RNF213-associated vascular disease: a concept unifying various vasculopathies","volume":"12","author":"Hiraide","year":"2022","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0085","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/STROKEAHA.124.046999","article-title":"Moyamoya vasculopathy and moyamoya-related systemic vasculopathy: a review with histopathological and genetic viewpoints","volume":"55","author":"Abumiya","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0090","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00701-014-2013-0","article-title":"Nationwide survey on quasi-moyamoya disease in Japan","volume":"156","author":"Hayashi","year":"2014","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0095","article-title":"Two cases of pulmonary arterial hypertension with specific vascular malformations and unique eosinophilic inflammation in carriers of the RNF213 p. Arg4810Lys variant: case series","volume":"42","author":"Takeda","year":"2023","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002317","article-title":"Genomic comparison with supercentenarians identifies RNF213 as a risk gene for pulmonary arterial hypertension","volume":"11","author":"Suzuki","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.healun.2019.08.022","article-title":"Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension","volume":"39","author":"Hiraide","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035009","article-title":"Prevalence and clinical characteristics of heterozygous RNF213 p.Arg4810Lys variant carriers diagnosed with chronic thromboembolic pulmonary hypertension","volume":"13","author":"Kiko","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.039002","article-title":"Balloon pulmonary angioplasty in heterozygous RNF213 p.Arg4810Lys variant carriers diagnosed with chronic thromboembolic pulmonary hypertension","volume":"14","author":"Kiko","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.chest.2017.09.023","article-title":"Nonsyndromic peripheral pulmonary artery stenosis is associated with homozygosity of RNF213 p.Arg4810Lys regardless of co-occurrence of moyamoya disease","volume":"153","author":"Chang","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7133\/jca.22-00021","article-title":"The genetic background of peripheral pulmonary artery stenosis","volume":"62","author":"Goto","year":"2022","journal-title":"J Jpn Coll Angiol"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0130","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jvir.2024.07.017","article-title":"Endovascular treatment for peripheral pulmonary arterial stenosis in RNF213-related vasculopathy","volume":"35","author":"Kwon","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0135","first-page":"2255","article-title":"Stenting of isolated pulmonary artery stenosis in an adult patient with RNF213 p.Arg4810Lys variant","volume":"40","author":"Kanezawa","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0140","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/ajmg.a.63370","article-title":"A Noonan-like pediatric patient with a de novo CBL pathogenic variant and an RNF213 polymorphism p.R4810K presenting with cardiopulmonary arrest due to left main coronary artery ostial atresia","volume":"191","author":"Chida-Nagai","year":"2023","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0145","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacasi.2023.05.002","article-title":"RNF213 p.R4810K variant increases the risk of vasospastic angina","volume":"3","author":"Ishiyama","year":"2023","journal-title":"JACC Asia"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0150","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jamacardio.2024.1483","article-title":"RNF213 variants, vasospastic angina, and risk of fatal myocardial infarction","volume":"9","author":"Hikino","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0155","article-title":"A histopathological report of a 16-year-old male with peripheral pulmonary artery stenosis and moyamoya disease with a homozygous RNF213 mutation","volume":"29","author":"Takahashi","year":"2020","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0160","article-title":"Clinical and immunopathological features of moyamoya disease","volume":"7","author":"Lin","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002146","article-title":"Biochemical and functional characterization of RNF213 (mysterin) R4810K, a susceptibility mutation of moyamoya disease, in angiogenesis in vitro and in vivo","volume":"4","author":"Kobayashi","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0170","doi-asserted-by":"crossref","first-page":"13191","DOI":"10.1038\/srep13191","article-title":"Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells","volume":"5","author":"Ohkubo","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0175","doi-asserted-by":"crossref","first-page":"26604","DOI":"10.1038\/s41598-024-77388-5","article-title":"CXCL12\/CXCR4 pathway as a novel therapeutic target for RNF213-associated pulmonary arterial hypertension","volume":"14","author":"Hiraide","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10143-024-02448-3","article-title":"Knockdown the moyamoya disease susceptibility gene, RNF213, upregulates the expression of basic fibroblast growth factor and matrix metalloproteinase-9 in bone marrow derived mesenchymal stem cells","volume":"47","author":"Li","year":"2024","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0185","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.111.040352","article-title":"Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease: from cardiovascular development to disease","volume":"125","author":"Kovacic","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/cells12010078","article-title":"RNF213 loss-of-function promotes angiogenesis of cerebral microvascular endothelial cells in a cellular state dependent manner","volume":"12","author":"Roy","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0195","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/WNR.0000000000000289","article-title":"Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene","volume":"25","author":"Sonobe","year":"2014","journal-title":"Neuroreport"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0200","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1007\/s12035-023-03480-y","article-title":"Rnf-213 knockout induces pericyte reduction and blood-brain barrier impairment in mouse","volume":"60","author":"Li","year":"2023","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0205","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1093\/brain\/awad225","article-title":"RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the hippo pathway","volume":"146","author":"Ye","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.devcel.2015.12.015","article-title":"Endothelial RSPO3 controls vascular stability and pruning through non-canonical WNT\/Ca(2+)\/NFAT signaling","volume":"36","author":"Scholz","year":"2016","journal-title":"Dev Cell"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0215","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1177\/0271678X241245557","article-title":"RNF213 variant and autophagic impairment: a pivotal link to endothelial dysfunction in moyamoya disease","volume":"44","author":"Shin","year":"2024","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163561","article-title":"Cellular functions and gene and protein expression profiles in endothelial cells derived from moyamoya disease-specific iPS cells","volume":"11","author":"Hamauchi","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbrc.2013.07.004","article-title":"Downregulation of securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients","volume":"438","author":"Hitomi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yjmcc.2023.07.008","article-title":"Novel signaling axis of FHOD1-RNF213-Col1\u03b1\/Col3\u03b1 in the pathogenesis of hypertension-induced tunica media thickening","volume":"182","author":"Chen","year":"2023","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018778155","article-title":"Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice","volume":"8","author":"Kobayashi","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.843927","article-title":"Ring finger protein 213 in moyamoya disease with pulmonary arterial hypertension: a mini-review","volume":"13","author":"Luo","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0245","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41586-024-08136-y","article-title":"A mechanism for hypoxia-induced inflammatory cell death in cancer","volume":"637","author":"Bhardwaj","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2025.06.001_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.687088","article-title":"RNF213 and GUCY1A3 in moyamoya disease: key regulators of metabolism, inflammation, and vascular stability","volume":"12","author":"Mineharu","year":"2021","journal-title":"Front Neurol"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725001455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725001455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:39:19Z","timestamp":1767800359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508725001455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0914508725001455"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.06.001","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNF213 and cardiovascular disease: A review of histopathological, genetic perspectives, and potential molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}